Surveillance of Escherichia coli From Frozen Chicken Meat in Fiji: Resistance Characteristics and Public Health Concerns Authors: Deepika Darshani Lata, Rana Fahmi Sabala, Akira Fukuda, Chie Nakajima, Yasuhiko Suzuki, Masaru Usui, Muhammad Asif Zahoor Published: 2025 ABSTRACT Antimicrobial resistance (AMR) is a growing concern in human and veterinary medicine. Misuse and overuse of antimicrobials in human medicine, veterinary medicine, agriculture, and aquaculture are major drivers of AMR development, with resistant bacteria also being selected in livestock and transmitted through meat. Research on AMR in livestock and animal‐derived foods is lacking in Fiji; thus, the associated risks remain unclear. Chicken is widely consumed in Fiji and is predominantly served frozen. This study is aimed at determining the prevalence and resistance profiles of Escherichia coli in frozen chicken meat from Fijian supermarkets. A total of 100 frozen chicken meat samples were purchased from supermarkets and retail outlets in Fiji for this study. E. coli was isolated from 72% of the samples. The E. coli isolates showed relatively high levels of resistance to ampicillin (36%), tetracycline (24%), and streptomycin (17%). Only one cefotaxime‐resistant isolate was obtained, which was identified as an extended‐spectrum β‐lactamase (ESBL)–producing bacterium. This isolate harbored the ESBL‐producing gene bla CTX-M-1 and was classified as ST2522. One colistin‐resistant isolate was obtained, and its resistance was attributed to a chromosomal mutation in the pmrB gene. The high level of intestinal bacterial contamination in frozen chicken meat suggests that improved hygiene management is necessary throughout the production and distribution chains. Furthermore, because resistance to antimicrobials is important in both human and veterinary medicine (cefotaxime‐ and colistin‐resistant E. coli), careful monitoring of AMR trends in Fiji is essential. These results suggest that AMR surveillance in meat and livestock is necessary to prevent its spread in Fiji. 1. Introduction The spread of antimicrobial resistance (AMR) poses a significant threat to global health, as it reduces the effectiveness of antimicrobials used to treat infections in humans and animals [1]. AMR bacteria can be transmitted from animals to humans through the consumption of contaminated food [2]. Therefore, effective AMR countermeasures require an understanding of the actual situation and interventions along the food chain. Chicken is a popular meat product in Fiji [3]. In most supermarkets and retail outlets, chicken meat is predominantly frozen. Fiji has an estimated 3.7 million live chickens, which meet approximately 80% of the domestic demand for chicken products [4]. Chicken meat is commonly contaminated with bacteria, including Escherichia coli, during handling, improper dressing, cleaning, and unhygienic practices in meat retailing [5]. Therefore, there are concerns about foodborne illnesses and the spread of AMR in chicken meat in Fiji. Although some countries have been collecting data on AMR, there is a notable lack of research on its use in livestock production in Fiji [6]. The prevalence of AMR in food animals in Fiji remains unclear, largely because of limited veterinary services and a lack of awareness of AMR among animal health professionals [7, 8]. E. coli is commonly used as an indicator for AMR monitoring. It is a commensal microorganism in the gastrointestinal tract of humans and many animals and is widely recognized as a reliable indicator of fecal contamination [9]. This study is aimed at clarifying the prevalence and resistance profiles of E. coli in frozen chicken meat in Fiji by isolating and characterizing E. coli from domestic and imported frozen chicken meat. 2. Material and Methods 2.1. Collection of Samples One hundred frozen chicken meat samples were purchased from retail outlets, butchers, and supermarkets in Fiji between January and March 2024. Samples were collected from seven towns and cities (Nadi, Lautoka, Sigatoka, Suva, Nausori, Labasa, and Savusavu) (Table S1). The samples included whole birds, cut pieces of chicken, minced chicken, thighs, drumsticks, and chicken breasts. Of the 100 samples collected, 80 were from locally produced frozen chicken, and 20 were from imported frozen chicken meat originating from New Zealand. The samples were transported under sterile conditions to the Animal Health Laboratory of the Biosecurity Authority of Fiji in Japan. 2.2. Isolation of E. coli After thawing, 25 g of the sample was cut into small pieces using sterile scissors and a scalpel and homogenized with 225 mL of Trypticase Soy Broth (Oxoid, Thermo Fisher Scientific Inc., United States). The mixture was thoroughly homogenized and incubated overnight at 37°C. A loopful of the enriched culture was streaked onto CHROMagar ECC (Kanto Chemical, Tokyo, Japan) and incubated at 37°C for 18–24 h. Three blue colonies, presumptively identified as E. coli, were selected and subcultured for further analysis. 2.3. Confirmation and Identification of the E. coli Isolates Bacterial identification was performed using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) with a Bruker MALDI Biotyper system (Bruker Daltonics, Bremen, Germany), following the manufacturer′s instructions and the method described by Croxatto et al. [10]. 2.4. Antimicrobial Susceptibility Testing The antimicrobial susceptibility of the confirmed E. coli isolates to 11 antimicrobials from eight different classes (ampicillin, cefazolin, cefotaxime, streptomycin, gentamicin, kanamycin, tetracycline, nalidixic acid, ciprofloxacin, colistin, and chloramphenicol; all sourced from Sigma‐Aldrich) was tested. The minimum inhibitory concentrations (MICs) of ampicillin, cefazolin, cefotaxime, streptomycin, gentamicin, kanamycin, tetracycline, nalidixic acid, ciprofloxacin, and chloramphenicol were determined using the agar dilution method for all isolates according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (2023). The MIC of colistin was determined using the microbroth dilution method according to the CLSI guidelines [11]. MIC values and dilution ranges were interpreted according to the CLSI breakpoints (2023) (except for streptomycin, for which the National Antimicrobial Resistance Monitoring System [NARMS] guidelines [2011] were followed). Isolates resistant to three or more antimicrobial classes are considered multidrug‐resistant [12]. 2.5. Phenotypic and Molecular Detection of ESBL‐Producing E. coli E. coli isolates resistant to ampicillin, cefazolin, and cefotaxime were tested for ESBL production using a double‐disc synergy test (DDST) according to the CLSI guidelines [11]. Paired discs of cefpodoxime (10 μg), ceftazidime (30 μg), cefotaxime (30 μg), and aztreonam (30 μg) were positioned at a distance of 20 mm (center to center) from the amoxicillin + clavulanic acid disc (AMC) (20 + 10 μg) (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan). Isolates resistant to cefotaxime and positive for DDST were screened for the presence of bla CTX-M using multiplex and singleplex PCR [13, 14]. The PCR products were purified using AMPure XP (Beckman Coulter, United States) and sequenced in both directions using the same primers designed for bla CTX-M gene amplification. Nucleotide sequences were determined using the BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific Inc.), and DNA alignments and deduced amino acid sequences were examined using the BLAST program (National Center for Biotechnology Information, United States). 2.6. Characterization of Colistin‐Resistant E. coli Isolates Isolates resistant to colistin, as determined by the broth microdilution method, were screened for the presence of mcr genes (mcr-1, mcr-2, mcr-3, mcr-4, mcr-5, mcr-6, mcr-7, mcr-8, mcr-9, and mcr-10) using multiplex PCR [15, 16]. Sequence analysis of pmrB, a gene associated with colistin resistance, was also performed. The entire pmrB gene was amplified for colistin‐resistant isolates using the forward primer 5′‐ACCAACACCCTGGAAGTGCATATCC‐3′ and reverse primer 5′‐TCCTCCAGGTTAACGGAGGAGAGTG‐3′ to amplify a 1304‐bp fragment [15]. The PCR products were subjected to sequence analysis, as described above. Chromosomal mutations associated with colistin resistance were identified using ResFinder (http://genepi.food.dtu.dk/resfinder). 2.7. Whole‐Genome Sequence Analysis of ESBL‐Producing E. coli ESBL‐producing E. coli isolates were subjected to whole‐genome sequencing analysis. Genomic DNA was extracted using the QIAquick PCR Purification Kit (QIAGEN, Hilden, Germany). The contig was mapped with 150‐bp paired‐end reads obtained using NEBNext Ultra II FS DNA (New England Biolabs, MO, United States) and NovaSeq sequencing platforms (Illumina, San Diego, CA, United States). Short reads were assembled using SPAdes (https://usegalaxy.eu/) with default parameters. Prokka and Staramr were used for sequence annotation and in silico detection of MLST and antibiotic resistance genes (https://usegalaxy.eu/). In addition, mobile genetic elements were detected in the assembled sequence. 2.8. Determination Genetic Context of bla CTX-M-1 The flanking region of the gene was compared with highly similar bla CTX-M-1 genes available in GenBank (http://www.ncbi.nlm.nih.gov/genebank/). NCBI E. coli isolates were recovered from human clinical samples isolated in Denmark (MK181567), Japan (LC567083), and the United Kingdom (CP099077), and from broiler samples studied in France (MG692622) and Switzerland (KJ484637). 2.9. Determination of E. coli Pathotype by Virulence Genes The multidrug‐resistant E. coli isolates were examined for specific pathotypes based on the virulence genes, including enterohemorrhagic E. coli (EHEC) and extraintestinal pathogenic E. coli (ExPEC). For EHEC and ExPEC, screening of the following virulence genes was performed using multiplex PCR: stx1, stx2, and eaeA for EHEC; cdt, cnf, hlyA, afa, aer, sfa/foc, pap, RPAi, ETTT, IroN, IHA, usp, kps, traT, FyuA, OmpT, ibeA, fimA1, and fimH for ExPEC. PCR was performed as described previously [17]. Based on molecular epidemiological criteria, isolates harboring two or more virulence genes will be classified as potential ExPEC [18]. 2.10. Statistical Analysis The variations in the resistance rates of E. coli isolates recovered from frozen local and imported chicken meat against the tested antibiotics were assessed using the chi‐square (χ 2) test and SPSS software v. 23.0 (IBM, Armonk, NY, United States). Statistical significance was set at p < 0.05. 3. Results 3.1. Prevalence of E. coli Isolates in the Samples E. coli was isolated from 72% (72/100) of frozen chicken meat samples. The prevalence of E. coli in local chicken meat was 65% (52/80), and that in imported chicken meat was 100% (20/20). The contamination rates of the different parts of the collected frozen chicken samples were 51% (18/35) for whole chickens, 89% (8/9) for cut chicken pieces, 100% (3/3) for minced chicken, 75% (9/12) for thighs, 85% (11/13) for drumsticks, and 82% (23/28) for breast meat. 3.2. Antimicrobial Susceptibility Up to three colonies were selected from each sample. Colonies with identical AMR profiles were considered as clones. All colonies isolated from the same sample in this study were clonal, and a total of 72 distinct E. coli strains were obtained from the 72 samples from which E. coli was isolated. Antimicrobial susceptibility testing of the 72 E. coli isolates showed that 36%, 24%, and 17% of the isolates were resistant to ampicillin, tetracycline, and streptomycin, respectively (Figure 1). Resistance to cefazolin and chloramphenicol was detected in 8% of the isolates. A lower percentage of isolates (1.4%–2.8%) were resistant to nalidixic acid, ciprofloxacin, kanamycin, cefotaxime, and colistin. All isolates were susceptible to gentamicin. Four isolates (4/72) classified as multidrug‐resistant were resistant to ampicillin, cefazolin, kanamycin, streptomycin, tetracycline, nalidixic acid, ciprofloxacin, and chloramphenicol. All four multidrug‐resistant strains were isolated from local frozen chicken (Table S2). Of these, two were from breast, whereas the remaining two were isolated from drumstick and whole chicken, respectively. Antimicrobial resistance profiles of E. coli (n = 72) derived from frozen chicken meat in Fiji: colistin (≥ 4 μg/mL), ampicillin (≥ 32 μg/mL), cefazolin (≥ 8 μg/mL), cefotaxime (≥ 4 μg/mL), streptomycin (≥ 64 μg/mL), kanamycin (≥ 64 μg/mL), gentamicin (≥ 16 μg/mL), tetracycline (≥ 16 μg/mL), nalidixic acid (≥ 32 μg/mL), and ciprofloxacin (≥ 4 μg/mL). Minimum inhibitory concentration (MIC) breakpoints were determined according to the CLSI (2023) guidelines. 3.3. Determination of ESBL Gene Only one isolate was resistant to cefotaxime (a third‐generation cephalosporin) and was positive for DDST. The isolate produced an ESBL that hydrolyzed third‐generation cephalosporins (such as cefotaxime, ceftazidime, and monobactam aztreonam). However, resistance was inhibited by clavulanic acid, as shown by the inhibition zone around the AMC used in the DDST. The isolate was obtained from a local chicken meat sample. Among the ESBL‐encoding genes screened, the isolate harbored bla CTX-M-1. 3.4. Characterization of Colistin‐Resistant Isolates Only one isolate was resistant to colistin and tested negative for all screened mcr genes. Molecular characterization revealed that colistin resistance in this isolate was due to a chromosomal mutation in the L279M amino acid of the pmrB gene, compared with wild‐type E. coli strains. This colistin‐resistant isolate was also resistant to ampicillin, cefazolin, streptomycin, and chloramphenicol. 3.5. The Whole‐Genome Sequence Analysis of the ESBL‐Producing E. coli In silico analysis based on MLST typing showed that the ST type of the ESBL‐producing E. coli isolate, LDDFJ026C, was ST2522. Several antibiotic resistance genes (bla CTX-M-1, sul2, tet (A), and tet (B)) were detected (Table 1). The plasmid replicon types of this isolate were IncFIA, IncFIA (HI1), IncFIB, IncHI1A, IncHI1B (R27), IncI1‐I, and IncX1. Table 1Whole‐genome sequence analysis of the ESBL‐producing E. coli. Isolate Phenotypic resistance profile Resistance genotype MLST Inc type LDDFJ026CAmpicillin, cefazolin, cefotaxime, tetracycline blaCTX-M-1, sul2, tet (A), tet (B) ST2522IncFIA, IncFIA (HI1), IncFIB (AP001918), IncHI1A, IncHI1B (R27), IncI1‐I (Alpha), IncX1 Whole‐genome sequence analysis of the ESBL‐producing E. coli. The flanking region of bla CTX-M-1 isolated from strain LDDFJ026C in this study was compared with that of NCBI E. coli isolates [19] (Figure 2). All isolates harbored the bla CTX-M-1 gene, which was encoded by an IncI1 plasmid. The flanking region of bla CTX-M-1 in E. coli 026C isolated in the current study was identical to the flanking region surrounding the bla CTX-M-1 genes detected in human clinical samples isolated in Denmark (MK181567) carrying ST3 and ST7 [20], in Japan (LC567083) ST3 [21], and in the United Kingdom (CP099077) ST131 and ST10 [22] and from broiler samples studied in France (MG692622) ST3 [19] and in Switzerland (KJ484637) ST3, ST36, and ST1 [23]. Of the six sequences, the gene was flanked by ISEcp1. Genomic schematic presentation of the flanking gene regions of the blaCTX-M-1 genes in the current study E. coli isolate (LDDFJ026C) and the NCBI E. coli isolates recovered from a human clinical sample isolated in Denmark (MK181567), Japan (LC567083), and the United Kingdom (CP099077) and from a broiler sample studied in France (MG692622) and in Switzerland (KJ484637). blaCTX-M-1: the resistant gene beta‐lactamase CTX‐M‐1; ISEcp1: the IS element IS1380 family transposase ISEcp1; orf477: cupin fold metalloprotein, WbuC family. 3.6. Determination of Multidrug‐Resistant E. coli Pathotype by Virulence Genes For the four multidrug‐resistant strains, the presence of virulence genes is shown in Table S2. Based on the virulence gene profiles, two strains were identified as STEC, and all were determined to be ExPEC. 4. Discussion The prevalence of E. coli in 100 frozen chicken meat samples from Fiji was 72% (72/100). Similar contamination rates by E. coli have been reported in previous studies, at 76% in Korea, 77% in Japan, and 79.68% in the United Arab Emirates [24–26]. High levels of bacterial contamination, especially E. coli, in poultry and poultry products are caused by direct or indirect fecal contamination during slaughter, dressing, and processing [27]. Several studies have shown that E. coli causes severe foodborne diseases and is transmitted to humans primarily through the consumption of contaminated chicken meat [28, 29]. Salmonella spp., Campylobacter, and pathogenic E. coli cause health problems worldwide, as they are the most important foodborne pathogens of the Enterobacteriaceae family and are transmitted through chicken meat [30, 31]. Therefore, hygienic precautions should be taken in the food processing chain to minimize the contamination of chicken meat by Enterobacteriaceae. The resistance rates of the 72 E. coli strains isolated from frozen chicken meat samples were relatively high for ampicillin, tetracycline, and streptomycin (Figure 1). In the current study, 6% (4/72) of the E. coli isolates were classified as multidrug‐resistant. Similarly, a study in New Zealand demonstrated that E. coli isolates from poultry were resistant to five antimicrobial classes: aminoglycosides, penicillins, quinolones, tetracyclines, and trimethoprim [32]. These resistant E. coli strains have the potential to transfer their resistance genes not only to other E. coli strains but also to other bacterial species in the gastrointestinal tract [33]. This highlights the risk of AMR spread within microbial communities, posing a significant public health threat. The detection of ESBL‐producing E. coli in chicken meat in this study was 1.4%. The isolation rate of ESBL‐producing E. coli from chicken meat varies depending on the country and the isolation method used [26, 27, 34]; however, the rate observed in this study tended to be lower compared with data reported from other countries. This low prevalence may reflect limited antimicrobial use in Fiji′s poultry industry, where small‐scale production and minimal importation of veterinary antibiotics reduce selective pressure for resistance. A survey of 276 livestock enterprises found that only 56% used antimicrobials, with 22% using only antibiotics [35]. Similarly, a national study in Australia reported no ESBL‐producing E. coli among isolates from commercial layer hens [36], suggesting low baseline resistance at the farm level. Continued adherence to prudent antimicrobial use and strengthened biosecurity can help maintain this low prevalence and safeguard both animal and public health. The cefotaxime‐resistant strain harbored the bla CTX-M-1 gene. This isolate was recovered from a local frozen chicken meat sample and has been reported for the first time in Fiji. The bla CTX-M family of genes, particularly bla CTX-M-1, is one of the most prevalent in cephalosporin‐resistant bacterial isolates originating from both humans and animals [37]. bla CTX-M-1 has been recovered from chicken meat samples in many countries, including China [38], United States [39], and Japan [25]. The isolate also harbored tetracycline resistance genes, tet (A) and tet (B). These genes are found in regions where tetracyclines are used as growth promoters or for prophylactic treatment [40]. In Fiji, beta‐lactams (ampicillin) and tetracyclines are among the most commonly imported veterinary antimicrobials and are frequently used in livestock [6, 41]. The use of antimicrobials in food‐producing animals is a significant driver of the selection and spread of AMR and AMR genes [42–44]. This necessitates continuous AMR surveillance and effective veterinary regulations regarding the use of antimicrobials in food‐producing animals in Fiji. The ST of the bla CTX-M-1 gene‐harboring E. coli isolate in the current study was ST2522. Previously, E. coli isolates of ST2522 have been recovered from fecal samples of sheep in Brazil [45], human clinical samples in the Netherlands [46], and water from vegetable farms in Portugal [47]. Interestingly, there are no previous reports of the isolation of E. coli ST2522 from food of animal origin, including chicken meat. These data suggest that ESBL‐producing E. coli isolates harboring bla CTX-M-1 ST2522 are transmitted through the food chain via cross‐contamination. Further investigations are warranted to assess the risks associated with food safety and public health. Colistin resistance was detected in 1.4% of the E. coli isolates. Molecular characterization revealed that no mcr genes were present in the isolate, whereas colistin resistance was attributed to a chromosomal mutation showing a substitution of L279M in the pmrB gene. Despite the growing awareness of polymyxin resistance and the global prevalence of mcr-1, there are few reports on the impact of chromosomal mutations on colistin and polymyxin B resistance in E. coli [48]. Furthermore, although amino acid substitutions in MgrB, PmrA/B, and PhoP/Q are common mechanisms of colistin resistance in K. pneumoniae in clinical settings, such mutations have rarely been reported in mcr‐negative colistin‐resistant E. coli isolates [49]. The colistin‐resistant E. coli in this study was suggested to be caused by a point mutation in the chromosomal pmrB gene; however, further studies are needed to elucidate the mechanisms of chromosomal colistin resistance in E. coli. The isolation of multidrug‐resistant and pathogenic E. coli harboring virulence genes indicating the presence of STEC and ExPEC from local chicken meat raises concerns regarding the risk of human infection, and warrants improved hygiene at chicken production and handling facilities. 5. Conclusion This study is the first to report E. coli contamination in frozen chicken meat samples from Fiji and evaluate the antimicrobial susceptibility of the recovered isolates. The study revealed a high prevalence of E. coli (72%), raising concerns about cross‐contamination of meat, sanitation, hygiene at processing plants, and handling of meat in supermarkets, butchers, and retail outlets. The E. coli isolate showed resistance to third‐generation cephalosporins, particularly cefotaxime, despite the extremely small amounts of veterinary antimicrobials imported into the country demonstrating the need to monitor the use of antimicrobials in the veterinary sector. Interestingly, among the recovered E. coli isolates, the ESBL‐producing isolate ST2522 harboring bla CTX-M-1, which was previously recovered from clinical samples, was identified. This indicates that food of animal origin is a potential source of AMR in human infections. Based on this study, regular monitoring and further studies on AMR profiling and prevalence in various food sources of animal origin in Fiji are recommended. Conflicts of Interest The authors declare no conflicts of interest. Author Contributions Deepika Darshani Lata: conceptualization, investigation, data analysis, sample curation, resources, and methodology, writing the original draft. Masaru Usui: conceptualization, data curation, investigation, project administration, resources, methodology, writing – review and editing. Rana Fahmi Sabala: data analysis, curation, writing – review and editing. Akira Fukuda: conceptualization, resources, methodology, writing – review and editing. Chie Nakajima: supervision. Yasuhiko Suzuki: supervision. Funding This work was supported in part by Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP20wm0125008 and JP223fa627005 to Y.S. Supporting Information Additional supporting information can be found online in the Supporting Information section. Supporting information Supporting Information 1 Table S1: Frozen chicken meat sample collection data in various towns and cities in Fiji. Supporting Information 2 Table S2: Pathotype profiling of multidrug‐resistant E. coli by detection of virulence genes from frozen chicken meat in Fiji.